A detailed history of Met Life Investment Management, LLC transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 29,317 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,317
Previous 29,317 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
N/A
15,533 Added 112.69%
29,317 $0
Q1 2024

May 14, 2024

BUY
N/A
13,784 New
13,784 $0
Q3 2023

May 09, 2024

BUY
N/A
13,784 New
13,784 $0
Q2 2023

Apr 29, 2024

BUY
N/A
13,784 New
13,784 $0
Q2 2023

Aug 10, 2023

BUY
N/A
13,784 New
13,784 $0
Q4 2021

Feb 15, 2022

SELL
$6.03 - $11.67 $54,860 - $106,173
-9,098 Closed
0 $0
Q3 2021

May 17, 2024

BUY
$9.98 - $35.22 $35,638 - $125,770
3,571 Added 64.61%
9,098 $90,000
Q3 2021

Jun 21, 2023

BUY
$9.98 - $35.22 $90,798 - $320,431
9,098 New
9,098 $90,000
Q3 2021

Mar 22, 2023

BUY
$9.98 - $35.22 $35,638 - $125,770
3,571 Added 64.61%
9,098 $90,000
Q3 2021

Nov 15, 2021

BUY
$9.98 - $35.22 $35,638 - $125,770
3,571 Added 64.61%
9,098 $91,000
Q1 2021

May 17, 2024

SELL
$37.62 - $60.41 $310,628 - $498,805
-8,257 Reduced 59.9%
5,527 $241,000
Q1 2021

Jun 26, 2023

BUY
$37.62 - $60.41 $207,925 - $333,886
5,527 New
5,527 $241 Million
Q1 2021

Mar 22, 2023

BUY
$37.62 - $60.41 $207,925 - $333,886
5,527 New
5,527 $241,000
Q1 2021

May 14, 2021

BUY
$37.62 - $60.41 $207,925 - $333,886
5,527 New
5,527 $241,000

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.